PHYTOCHEMICALS AND COMPLICATIONS IN TYPE 2 DIABETES-AN UPDATE

被引:6
|
作者
Oza, Manisha J. [1 ,2 ]
Kulkarni, Yogesh A. [1 ]
机构
[1] SVKMs NMIMS, Shobhaben Pratapbhai Patel Sch Pharm & Technol Ma, Bombay 400056, Maharashtra, India
[2] SVKMs Dr Bhanuben Nanavati Coll Pharm, Bombay, Maharashtra, India
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH | 2016年 / 7卷 / 01期
关键词
Cardiovascular Diseases; Nephropathy; Neuropathy; Peripheral Artery Diseases; Phytoconstituents; Retinopathy; Type; 2; Diabetes;
D O I
10.13040/IJPSR.0975-8232.7(1).14-24
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Type 2 diabetes is a serious health problem globally. In type 2 diabetes insulin resistance in various tissues such as liver, muscle and beta-cell is the major pathophysiological defects. People with long term uncontrolled hyperglycemia are at risk of developing a number of serious and life-threatening complications which mainly affect the heart and blood vessels, eyes, kidneys, and nerves. Current drug development strategy has focused towards the control of hyperglycemia but the treatment of severe complications has been neglected. Many herbs including Momordica charantia, Coccinia indica, Ficus carica, Gymnema sylvestre, Ocimum santum and many more have traditionally been used for the treatment of diabetes and associated complications. Natural products have been reported to have their efficacy in diabetes and its complications by protecting pancreatic beta-cells, increasing insulin sensitivity, reducing oxidative stress and by targeting various proteins. Thus, now a day plant based natural product (phytoconstituents) have been the basis of drug development program for the treatment of various diseases. The present review summarizes the latest updates on phytochemicals from different class of secondary metabolites with potential effect in type 2 diabetic complications.
引用
收藏
页码:14 / 24
页数:11
相关论文
共 50 条
  • [21] Effectiveness of Sitagliptin in Asian Indian Patients with Type 2 Diabetes-An Indian Tertiary Diabetes Care Center Experience
    Sudhakaran, Chidambarann
    Kishore, Utkal
    Anjana, Ranjit Mohan
    Unnikrishnan, Ranjit
    Mohan, Viswanathan
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (01) : 27 - 32
  • [22] Predictors of Hypoglycemia in Patients With Type-2 Diabetes-An Analysis of the Prospective DiaRegis Registry
    Tschope, Diethelm
    Bramlage, Peter
    Binz, Christiane
    Krekler, Michael
    Loebner, Kristian
    Deeg, Evelin
    Gitt, Anselm K.
    DIABETES, 2012, 61 : A554 - A554
  • [23] Prevention of type 2 diabetes: An update
    Farag A.
    Karam J.
    Nicasio J.
    McFarlane S.I.
    Current Diabetes Reports, 2007, 7 (3) : 200 - 207
  • [24] Controversies in type 2 diabetes An update
    Yeap, Bu B.
    AUSTRALIAN FAMILY PHYSICIAN, 2009, 38 (1-2) : 22 - 25
  • [25] Update on the Prevention of Type 2 Diabetes
    Karam, Jocelyne G.
    McFarlane, Samy I.
    CURRENT DIABETES REPORTS, 2011, 11 (01) : 56 - 63
  • [26] Update on type 2 diabetes care
    不详
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2011, 15 (9-10): : 4 - 7
  • [27] Pharmacotherapy of type 2 diabetes: An update
    Upadhyay, Jagriti
    Polyzos, Stergios A.
    Perakakis, Nikolaos
    Thakkar, Bindiya
    Paschou, Stavroula A.
    Katsiki, Niki
    Underwood, Patricia
    Park, Kyung-Hee
    Seufert, Jochen
    Kang, Eun Seok
    Sternthal, Elliot
    Karagiannis, Asterios
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 78 : 13 - 42
  • [28] Update on the Prevention of Type 2 Diabetes
    Jocelyne G. Karam
    Samy I. McFarlane
    Current Diabetes Reports, 2011, 11 : 56 - 63
  • [29] Complications and comorbidities of type 2 diabetes
    Norris, AW
    Svoren, BM
    PEDIATRIC ANNALS, 2005, 34 (09): : 710 - 718
  • [30] Complications of the Type 2 Diabetes Mellitus
    Farmaki, Paraskevi
    Damaskos, Christos
    Garmpis, Nikolaos
    Garmpi, Anna
    Savvanis, Spyridon
    Diamantis, Evangelos
    CURRENT CARDIOLOGY REVIEWS, 2020, 16 (04) : 249 - 251